What Pharma Giant Johnson & Johnson’s CEO Has to Say About the Drug Price Debate

A television report saying U.S. companies are lobbying the British government over drug prices was a topic of debate in Britain’s Parliament on Wednesday in what is expected to be a hot topic in the run-up to December’s U.K. general election......»»

Shares of Johnson & Johnson slipped 0.1% in premarket trading Wednesday, after the consumer products and drug giant reported a fourth-quarter profit that beat expectations but revenue that came up a bit shy. Net income rose to $4.01 billion, o.....»»

Critics say $8 billion award against the pharmaceuticals giant is a symbol of consumer anger......»»

Critics say $8 billion award against the pharmaceuticals giant is a symbol of consumer anger......»»

An Oklahoma judge on Monday found Johnson & Johnson and its subsidiaries helped fuel the state's and ordered the consumer products giant to pay $572 million, more than twice the amount another drug... To view the full story, click the title link......»»

Shares of Johnson & Johnson gained 1.0% in premarket trade Tuesday, after the drug and consumer products giant reported first-quarter earnings and revenue that rose above expectations, and raised its full-year sales growth outlook. Net .....»»

Johnson & Johnson Vs. Pfizer: Which Big Pharma Giant Is The Better Dividend Stock?.....»»

Geron's experimental blood cancer drug remains a top priority for the pharma behemoth Johnson & Johnson......»»

Pharma giant Eli Lilly and Co. will buy small cancer immunotherapy drug developer ARMO BioSciences Inc., a Redwood City company that went public in January, in a $1.6 billion all-cash deal. Lilly's $50-per-share buyout is nearly three times ARMO's (.....»»

Pharma giant Eli Lilly and Co. will buy small cancer immunotherapy drug developer ARMO BioSciences Inc., a Redwood City company that went public in January, in a $1.6 billion all-cash deal. Lilly's $50-per-share buyout is nearly three times ARMO's (NA.....»»

AP Merck said Thursday that it would lower the price of some of its medications including its hepatitis C drug Zepatier by 60%.  The decision comes a little over a week after President Donald J. Trump singled out ri.....»»

Hollis Johnson Popular DNA testing companies like Ancestry and 23andMe can — and frequently do — sell your data to drug makers. On Wednesday, pharmaceutical giant GlaxoSmithKline announced it was acquiring a $300 mi.....»»

Pharma Remains The Key Debate For Johnson & Johnson, But Other Segments Showing Signs Of A Recovery.....»»

The pharma giant said 41 drugs would see a price increase, representing 10 percent of its product portfolio. M.....»»

The pharma giant said 41 drugs would see a price increase, representing 10 percent of its product portfolio. M.....»»

A simple nasal swab to detect early-stage lung cancer — perhaps even before symptoms appear — landed a South San Francisco diagnostics company a potential $20 million deal with health care giant Johnson & Johnson. Although the deal gives Vera.....»»

Brainstorm Health Daily: February 12, 2019 Hello, readers. Drug giant Johnson & Johnson enjoyed a 1.6% stock boost on Tuesday after a crucial Food and Drug Administration (FDA) advisory committee vote recommending approval of its in.....»»

Johnson & Johnson has agreed to buy surgical robotics company Auris Health Inc. for about $3.4 billion in cash, in a deal that would give the drug giant a lung-cancer diagnostic and treatment tool......»»

Johnson & Johnson has agreed to buy surgical robotics company Auris Health Inc. for about $3.4 billion in cash, in a deal that would give the drug giant a lung-cancer diagnostic and treatment tool......»»

Auris Medical Holding AG got a surprise boost to its stock price Wednesday as investors mistakenly bought shares of the drug developer after Johnson & Johnson agreed to buy a similarly named robotics company for $3.4 billion......»»